IRadimed Corporation (IRMD) Insider Trading Activity

NASDAQ$93.4-2.16 (-2.26%)
Market Cap
$1.22B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
630 of 875
Rank in Industry
80 of 111

IRMD Insider Trading Activity

IRMD Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$16,175,944
36
100

Related Transactions

ALLEN MONTY Kdirector
0
$0
2
$176,405
$-176,405
HAWKINS JAMES Bdirector
0
$0
2
$554,554
$-554,554
GLENN JOHNCHIEF FINANCIAL OFFICER
0
$0
2
$2.36M
$-2.36M
Susi Roger E.CEO, PRESIDENT, CHAIRMAN
0
$0
30
$13.09M
$-13.09M

About IRadimed Corporation

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Insider Activity of IRadimed Corporation

Over the last 12 months, insiders at IRadimed Corporation have bought $0 and sold $16.18M worth of IRadimed Corporation stock.

On average, over the past 5 years, insiders at IRadimed Corporation have bought $0 and sold $12.51M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000 shares for transaction amount of $27,700 was made by Susi Roger E. (CEO, President, Chairman) on 2018‑03‑16.

List of Insider Buy and Sell Transactions, IRadimed Corporation

2026-04-07SaleSusi Roger E.CEO, President, Chairman
2,500
0.0198%
$94.84
$237,098
+1.44%
2026-04-06SaleSusi Roger E.CEO, President, Chairman
5,000
0.0393%
$96.02
$480,110
-0.70%
2026-03-30SaleSusi Roger E.CEO, President, Chairman
7,500
0.0587%
$95.02
$712,614
+1.10%
2026-03-24SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
2,500
0.0194%
$100.28
$250,697
-3.55%
2026-03-23SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0396%
$100.38
$501,912
-3.84%
2026-03-17SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
2,500
0.0195%
$102.43
$256,075
-5.33%
2026-03-16SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.039%
$101.38
$506,896
-4.08%
2026-03-10SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
2,500
0.0196%
$100.11
$250,275
+0.42%
2026-03-09SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0398%
$100.04
$500,200
-1.02%
2026-03-06SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
7,500
0.0588%
$98.39
$737,919
+0.66%
2026-02-13SaleALLEN MONTY Kdirector
1,000
0.0079%
$100.26
$100,256
+0.48%
2026-01-26SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0395%
$100.65
$503,255
-0.26%
2026-01-20SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0389%
$101.84
$509,225
-3.01%
2026-01-12SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0391%
$97.45
$487,231
+2.22%
2026-01-05SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0391%
$97.68
$488,417
+1.61%
2025-12-29SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0394%
$97.66
$488,317
+2.15%
2025-12-22SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0391%
$96.73
$483,672
+2.76%
2025-12-15SaleSusi Roger E.CEO, PRESIDENT, CHAIRMAN
5,000
0.0392%
$96.75
$483,729
+2.85%
2025-12-11SaleGLENN JOHNCHIEF FINANCIAL OFFICER
15,000
0.1178%
$97.29
$1.46M
+2.41%
2025-12-09SaleHAWKINS JAMES Bdirector
3,000
0.0235%
$96.61
$289,838
+3.02%
Total: 417
*Gray background shows transactions not older than one year

Insider Historical Profitability

34.2%
Susi Roger E.CEO, President, Chairman
2217500
17.3478%
$211.9M5156
+15.44%
HAWKINS JAMES Bdirector
28742
0.2249%
$2.75M125
+64.84%
ALLEN MONTY Kdirector
21000
0.1643%
$2.01M020
GLENN JOHNCHIEF FINANCIAL OFFICER
7362
0.0576%
$703,512.7203
Novovich Sergedirector
104636
0.8186%
$10M04
Casey Francis X.VP of Reg and Qual Assurance
50831
0.3977%
$4.86M03
McCreery John KChief Operating Officer
16625
0.1301%
$1.59M02
VUOTO ANTHONYdirector
14234
0.1114%
$1.36M09
Scott Christopher K.CFO & Secretary
13710
0.1073%
$1.31M08
JOHNSON BRENTExec. VP of WW Sales and Mktg
2940
0.023%
$280,946.400151
Nardi Steven M.VP Manufacturing
0
0%
$0214
+65.78%
Waldman Louis S.Controller
0
0%
$0014
*Gray background shows insiders who have made transactions during last year

IRMD Institutional Investors: Active Positions

Increased Positions117+56.52%1M+17.92%
Decreased Positions89-43%720,699-10.42%
New Positions51New570,041New
Sold Out Positions16Sold Out48,441Sold Out
Total Postitions235+13.53%7M+7.5%

IRMD Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$97,016.007.81%1.02M+53,535+5.56%2025-09-30
Nine Ten Capital Management Llc$73,667.005.93%771,384-100,619-11.54%2025-09-30
Vanguard Group Inc$54,101.004.36%566,507+5,475+0.98%2025-09-30
Renaissance Technologies Llc$46,677.003.76%488,762-3,050-0.62%2025-09-30
Copeland Capital Management, Llc$41,399.003.34%433,500-24,419-5.33%2025-09-30
Geode Capital Management, Llc$25,435.002.05%266,339+4,953+1.9%2025-09-30
Dimensional Fund Advisors Lp$20,490.001.65%214,551-875-0.41%2025-09-30
State Street Corp$17,881.001.44%187,239+9,850+5.55%2025-09-30
Goldman Sachs Group Inc$14,306.001.15%149,801+6,099+4.24%2025-09-30
Acadian Asset Management Llc$13,874.001.12%145,278-8,961-5.81%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.